Folgen
Giorgio Perilongo
Giorgio Perilongo
Professore di Pediatria, Università di Padova
Bestätigte E-Mail-Adresse bei aopd.veneto.it
Titel
Zitiert von
Zitiert von
Jahr
Whole-brain irradiation and decline in intelligence: the influence of dose and age on IQ score.
JH Silber, J Radcliffe, V Peckham, G Perilongo, P Kishnani, M Fridman, ...
Journal of clinical oncology 10 (9), 1390-1396, 1992
4171992
2005 PRETEXT: a revised staging system for primary malignant liver tumours of childhood developed by the SIOPEL group
DJ Roebuck, D Aronson, P Clapuyt, P Czauderna, J de Ville de Goyet, ...
Pediatric radiology 37, 123-132, 2007
3722007
Liver transplantation for hepatoblastoma: results from the International Society of Pediatric Oncology (SIOP) study SIOPEL‐1 and review of the world experience
JB Otte, J Pritchard, DC Aronson, J Brown, P Czauderna, R Maibach, ...
Pediatric blood & cancer 42 (1), 74-83, 2004
3652004
Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: final results of the SIOPEL-3HR study
J Zsíros, R Maibach, E Shafford, L Brugieres, P Brock, P Czauderna, ...
J Clin Oncol 28 (15), 2584-2590, 2010
3602010
Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children's Hepatic tumors International Collaboration
RL Meyers, R Maibach, E Hiyama, B Häberle, M Krailo, A Rangaswami, ...
The Lancet Oncology 18 (1), 122-131, 2017
3472017
Pretreatment prognostic factors for children with hepatoblastoma—results from the International Society of Paediatric Oncology (SIOP) study SIOPEL 1
J Brown, G Perilongo, E Shafford, J Keeling, J Pritchard, P Brock, ...
European Journal of Cancer 36 (11), 1418-1425, 2000
3452000
Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma
G Perilongo, R Maibach, E Shafford, L Brugieres, P Brock, B Morland, ...
New England Journal of Medicine 361 (17), 1662-1670, 2009
3442009
Risk-adapted treatment for childhood hepatoblastoma: Final report of the second study of the International Society of Paediatric Oncology—SIOPEL 2
G Perilongo, E Shafford, R Maibach, D Aronson, L Brugieres, P Brock, ...
European Journal of Cancer 40 (3), 411-421, 2004
3442004
Cisplatin, doxorubicin, and delayed surgery for childhood hepatoblastoma: a successful approach—results of the first prospective study of the International Society of …
J Pritchard, J Brown, E Shafford, G Perilongo, P Brock, C Dicks-Mireaux, ...
Journal of clinical oncology 18 (22), 3819-3828, 2000
3192000
Hepatocellular carcinoma in children: results of the first prospective study of the International Society of Pediatric Oncology group
P Czauderna, G Mackinlay, G Perilongo, J Brown, E Shafford, D Aronson, ...
Journal of Clinical Oncology 20 (12), 2798-2804, 2002
3142002
Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study
J Zsiros, L Brugieres, P Brock, D Roebuck, R Maibach, A Zimmermann, ...
The lancet oncology 14 (9), 834-842, 2013
3132013
Improved survival with the use of adjuvant chemotherapy in the treatment of medulloblastoma
RJ Packer, LN Sutton, JW Goldwein, G Perilongo, G Bunin, J Ryan, ...
Journal of neurosurgery 74 (3), 433-440, 1991
2831991
Sodium thiosulfate for protection from cisplatin-induced hearing loss
PR Brock, R Maibach, M Childs, K Rajput, D Roebuck, MJ Sullivan, ...
New England Journal of Medicine 378 (25), 2376-2385, 2018
2772018
The Children's Hepatic tumors International Collaboration (CHIC): novel global rare tumor database yields new prognostic factors in hepatoblastoma and becomes a research model
P Czauderna, B Haeberle, E Hiyama, A Rangaswami, M Krailo, ...
European Journal of cancer 52, 92-101, 2016
2732016
Surgical view of the treatment of patients with hepatoblastoma: Results from the first prospective trial of the International Society of Pediatric Oncology Liver Tumor Study …
JM Schnater, DC Aronson, J Plaschkes, G Perilongo, J Brown, JB Otte, ...
Cancer 94 (4), 1111-1120, 2002
2572002
Predictive value of the pretreatment extent of disease system in hepatoblastoma: results from the International Society of Pediatric Oncology Liver Tumor Study Group SIOPEL-1 study
DC Aronson, JM Schnater, CR Staalman, GJ Weverling, J Plaschkes, ...
Journal of clinical oncology 23 (6), 1245-1252, 2005
2542005
Undifferentiated sarcoma of the liver in childhood: a curable disease
G Bisogno, T Pilz, G Perilongo, A Ferrari, D Harms, V Ninfo, J Treuner, ...
Cancer 94 (1), 252-257, 2002
2412002
Medulloblastoma with extensive nodularity: a variant with favorable prognosis
F Giangaspero, G Perilongo, MP Fondelli, M Brisigotti, C Carollo, ...
Journal of neurosurgery 91 (6), 971-977, 1999
2341999
Analyses of prognostic factors in a retrospective review of 92 children with ependymoma: Italian Pediatric Neuro‐Oncology Group
G Perilongo, M Massimino, G Sotti, T Belfontali, L Masiero, L Rigobello, ...
Medical and Pediatric Oncology: The Official Journal of SIOP—International …, 1997
2331997
Methotrexate treatment in juvenile localized scleroderma: a randomized, double‐blind, placebo‐controlled trial
F Zulian, G Martini, C Vallongo, F Vittadello, F Falcini, A Patrizi, M Alessio, ...
Arthritis & Rheumatism 63 (7), 1998-2006, 2011
2252011
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20